Boston Bulks Up Against Embo Bead Rivals With CeloNova Deal
This article was originally published in Clinica
Executive Summary
Boston Scientific has agreed to acquire the interventional radiology portfolio of CeloNova Biosciences, gaining three new microsphere technologies that will expand its presence in the embolization therapy and drug-eluting beads space.